TELESTA THERAPEUTICS INC T.TST

I see the Vetoquinol release

[Nohandledzep]

on CNW but where is the Bioniche release? They seem quite happy about the arrangement and I am happy for them. They look like nice people and apparently Animal Health is a nice fit for them.

But is the 2 line statement by the CEO all that Bioniche have to say to shareholders? If all I were able to gross were 55 mil Canadian I might be embarassed and short winded about it as well, but I assume that we shareholders will here something before the circular justifying less than 2yrs revenue.

After commission fees and debt repayment they might net 3 mil, and probably half that after severance costs. Obviously we'll all have to vote for it as the contingency and plan B will be insolvency.

Great deal. I am glad that they were able to pull it together. We should all feel well rewarded for the 9 months of effort.

[beechguy]

The only chance we have if we don't ratify this deal, is if we get a Urocidin partner before June 30th with a lot of up front cash (around 60mm!!) That isn't a dice roll I'm willing to take. At least now someone can make a rational decision based on what is in front of them. If you like Urocidin and think a partner is on the way, you buy or hold. If not you sell. Graeme's "Let

[conspiTheory]

absolutely, nobody shows and will show up ever with the last structure, this is lighter and easier to explain to your shareholders base why you want to buy BNC. Sell it!

[bailmeout]

I feel much better now that I sold 90% of my shares off over the last 3 months..I knew this was the way it was going down..it's the one thing I have learned about BNC over the last 8 years.. Expect nothing from them and you wont be dissapointed.

[supserstar]

so let me get this straight....BNC had an asset generating $8 million per year in cash flow, but the company was spending $6 million per year in interest and $14 million per year in excessive spending/burning so was losing around $12 million per year in total. It has a very attractive phase 3 cancer drug with substantial upside, but had no way to get that drug to market because it had $60

[supserstar]

- a couple of corrections on my post. the second paragraph was supposed to say in the last line that they would reduce all the debt and leave bnc with $40 million in cash, not reduce it to $40 million in debt. - the second last paragraph was supposed to say a %20 royalty not a $20 royalty. Last thought...AH did generate $32 million in revenue but only $8 million in EBITDA. that is a 25% gross

[chrispi]

Excellent analysis superstar. One of the few on this insane board that gets it ! This company is worth multiples of its current sp by the end of this year. The funds can clearly analyze this "less complex" company now and reward it appropriately. A few more events (gov't dismall of debt and pharma parnership) and we have an entirely new company. For those that are quick to writeoff

[bailmeout]

Selling AH is the only thing they had that was profitable..still huge burn rate for vmc and quebec plant.. just no income anymore. you need to read up a bit before you shoot your mouth off as to who is who around here :).. P.S. I made about 300% with what I sold.. check MBX 

[ragingbull1327]

Your post sounds reasonable, but your logic falls apart because we are talking about BNC